KENALOG-10 Side Effects

6967556-6 | Acne, Blood Pressure Increased, Dyspepsia, Flatulence, Heart Rate Increased, Insomnia, Migraine, Swelling Face
on Aug 31, 2010 Female patient from UNITED STATES , 47 years of age, weighting 180.8 lb, was treated with Kenalog-10 (View Usage). Patient experienced the following unwanted or unexpected effects: acne (What is acne?), blood pressure increased, dyspepsia, flatulence, heart rate increased, insomnia, migraine (What is migraine?), swelling face. Kenalog-10 dosage: . During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

6591148-4 | Urticaria
Patient was taking Kenalog-10 (View Usage). Patient had the following side effects: urticaria on Jul 22, 2009 from UNITED STATES Additional patient health information: Female patient , 38 years of age, was diagnosed with alopecia areata, oral contraception and. Kenalog-10 dosage: . During the same period patient was treated with VALTREX (View Valtrex Review and Valtrex Label ), AVIANE 28 (View Aviane-28 Review and Aviane-28 Label ).

6591143-5 | Blood Pressure Increased, Dizziness, Heart Rate Increased
Adverse event was reported on Jun 23, 2009 by a Female patient taking Kenalog-10 (View Usage) (Dosage: ) was diagnosed with eyelid cyst and. Location: UNITED STATES , 45 years of age, weighting 94.80 lb, After Kenalog-10 was administered, patient had the following side effects: blood pressure increased, dizziness (What is dizziness?), heart rate increased. During the same period patient was treated with MOTRIN (View Motrin Review and Motrin Label ).

6591139-3 | Acne, Hair Growth Abnormal, Headache, Hypertension, Peripheral Vascular Disorder, Weight Increased
on Jun 02, 2009 Female patient from UNITED STATES , 31 years of age, weighting 185.2 lb, was diagnosed with back disorder and was treated with Kenalog-10 (View Usage). Patient experienced the following unwanted or unexpected effects: acne (What is acne?), hair growth abnormal, headache (What is headache?), hypertension, peripheral vascular disorder, weight increased. Kenalog-10 dosage: Taken 3 Months Ago. During the same period patient was treated with MOTRIN (View Motrin Review and Motrin Label ), TRAMADOL (View Tramadol Review and Tramadol Label ).


6453353-7 | Anxiety, Lacrimation Increased, Product Quality Issue, Scar, Skin Discolouration
on Nov 23, 2009 Female patient from UNITED STATES , 15 years of age, weighting 105.0 lb, was diagnosed with acne cystic and was treated with Kenalog-10 (View Usage). Patient had the following side effects: anxiety (What is anxiety?), lacrimation increased, product quality issue, scar (What is scar?), skin discolouration. Kenalog-10 dosage: 0.2 Cc Once.

6092597-3 | Injection Site Reaction
Patient was taking Kenalog-10 (View Usage). After Kenalog-10 was administered, patient had the following side effects: injection site reaction on Jun 25, 2008 from UNITED STATES Additional patient health information: Male patient , 30 years of age, . Kenalog-10 dosage: It Is A Second Injection.. During the same period patient was treated with PERCOCET (View Percocet Review and Percocet Label ), VALIUM (View Valium Review and Valium Label ).

6092585-7 | Injection Site Discolouration
Adverse event was reported on Mar 25, 2008 by a Male patient taking Kenalog-10 (View Usage) (Dosage: ) was diagnosed with swelling and. Location: UNITED STATES , 63 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: injection site discolouration. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ).

6092576-6 | Glaucoma
on Apr 14, 2008 Male patient from UNITED STATES , 70 years of age, weighting 216.1 lb, was treated with Kenalog-10 (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?). Kenalog-10 dosage: . During the same period patient was treated with DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5932869-3 | Anaphylactic Reaction, Headache, Ill-defined Disorder, Insomnia, Irritability, Malaise, Menstrual Disorder, Muscular Weakness, Nausea
on Oct 27, 2008 Female patient from UNITED STATES , 47 years of age, weighting 127.0 lb, was treated with Kenalog-10 (View Usage). After Kenalog-10 was administered, patient had the following side effects: anaphylactic reaction, headache (What is headache?), ill-defined disorder, insomnia, irritability, malaise, menstrual disorder, muscular weakness, nausea (What is nausea?). Kenalog-10 dosage: . During the same period patient was treated with KENALOG 40 (View Kenalog-40 Review and Kenalog-40 Label ). Patient was hospitalized.

5637253-8 | Staphylococcal Infection
Patient was taking Kenalog-10 (View Usage). Patient experienced the following unwanted or unexpected effects: staphylococcal infection (What is staphylococcal infection?) on Aug 13, 2007 from UNITED STATES Additional patient health information: Female patient , 47 years of age, . Kenalog-10 dosage: .

5637252-6 | Staphylococcal Infection
Adverse event was reported on Aug 13, 2007 by a Female patient taking Kenalog-10 (View Usage) (Dosage: ) . Location: UNITED STATES , 26 years of age, Patient had the following side effects: staphylococcal infection (What is staphylococcal infection?).

5383880-5 | Chest Discomfort, Pruritus
on Jul 09, 2007 Female patient from UNITED KINGDOM , 64 years of age, was treated with Kenalog-10 (View Usage). After Kenalog-10 was administered, patient had the following side effects: chest discomfort, pruritus. Kenalog-10 dosage: . During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), CODEINE PHOSPHATE AND ACETAMINOPHEN (View Codeine Phosphate And Acetaminophen Review and Codeine Phosphate And Acetaminophen Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

5272511-0 | Alopecia, Fat Atrophy, Injection Site Atrophy
on Oct 06, 2006 Female patient from UNITED STATES , 54 years of age, weighting 110.2 lb, was diagnosed with muscle twitching and was treated with Kenalog-10 (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, fat atrophy, injection site atrophy. Kenalog-10 dosage: . During the same period patient was treated with BOTOX (View Botox Review and Botox Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ), PREMARIN (View Premarin Review and Premarin Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

5272476-1 | Hypersensitivity
Patient was taking Kenalog-10 (View Usage). Patient had the following side effects: hypersensitivity on Feb 01, 2006 from UNITED STATES Additional patient health information: Female patient , 16 years of age, was diagnosed with hypertrophic scar and. Kenalog-10 dosage: . During the same period patient was treated with MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

5262467-9 | Abdominal Pain Upper, Back Pain, Breast Pain, Chest Pain, Dark Circles Under Eyes, Dry Skin, Dyspnoea, Epistaxis, Haemorrhage
Adverse event was reported on Mar 09, 2007 by a Female patient taking Kenalog-10 (View Usage) (Dosage: 10cc Per Mg Once Im) was diagnosed with melanocytic naevus and. Location: UNITED STATES , 46 years of age, After Kenalog-10 was administered, patient had the following side effects: abdominal pain upper, back pain (What is back pain?), breast pain, chest pain (What is chest pain?), dark circles under eyes, dry skin, dyspnoea, epistaxis, haemorrhage.

4893495-0 | Injection Site Discolouration
on Nov 29, 2005 Female patient from UNITED STATES , 42 years of age, weighting 116.8 lb, was diagnosed with dermal cyst and was treated with Kenalog-10 (View Usage). Patient experienced the following unwanted or unexpected effects: injection site discolouration. Kenalog-10 dosage: . During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

4893483-4 | Hypersensitivity
on Jul 27, 2005 Female patient from UNITED STATES , 16 years of age, was diagnosed with hypertrophic scar and was treated with Kenalog-10 (View Usage). Patient had the following side effects: hypersensitivity. Kenalog-10 dosage: . During the same period patient was treated with MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

4893481-0 | Haemorrhage Subcutaneous
Patient was taking Kenalog-10 (View Usage). After Kenalog-10 was administered, patient had the following side effects: haemorrhage subcutaneous on Jul 14, 2005 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 130.1 lb, was diagnosed with tendonitis and. Kenalog-10 dosage: .

4893467-6 | Hypersensitivity
Adverse event was reported on Jan 24, 2005 by a Female patient taking Kenalog-10 (View Usage) (Dosage: ) was diagnosed with plantar fasciitis and. Location: UNITED STATES , 55 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: hypersensitivity.

4893465-2 | Tendon Rupture
on Dec 16, 2004 Female patient from UNITED STATES , 41 years of age, was diagnosed with eczema (What is eczema?) and was treated with Kenalog-10 (View Usage). Patient had the following side effects: tendon rupture. Kenalog-10 dosage: Number Of Doses: A Series Of Intralesional Injections.. During the same period patient was treated with DIPROLENE (View Diprolene Review and Diprolene Label ), PREMPHASE 14/14 (View Premphase 14/14 Review and Premphase 14/14 Label ), INDERAL (View Inderal Review and Inderal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DETROL (View Detrol Review and Detrol Label ), PROTOPIC (View Protopic Review and Protopic Label ).

4562408-3 | Injection Site Reaction
on Sep 29, 2004 Female patient from , 40 years of age, weighting 125.7 lb, was diagnosed with neck pain, headache (What is headache?) and was treated with Kenalog-10 (View Usage). After Kenalog-10 was administered, patient had the following side effects: injection site reaction. Kenalog-10 dosage: . During the same period patient was treated with CLORAZEPATE DIPOTASSIUM (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ).

4562399-5 | Injection Site Discolouration, Muscle Atrophy
Patient was taking Kenalog-10 (View Usage). Patient experienced the following unwanted or unexpected effects: injection site discolouration, muscle atrophy on Jun 09, 2004 from Additional patient health information: Male patient , weighting 28.66 lb, was diagnosed with gastroenteritis viral, retching and. Kenalog-10 dosage: In Right Thigh. During the same period patient was treated with ROCEPHIN (Injection) (View Rocephin Review and Rocephin Label ).

4562397-1 | Cellulitis
Adverse event was reported on May 11, 2004 by a Female patient taking Kenalog-10 (View Usage) (Dosage: 5mg/cc; Injected Into Heel Area Of Foot) was diagnosed with eczema (What is eczema?) and. Location: , 45 years of age, Patient had the following side effects: cellulitis (What is cellulitis?).

4562390-9 | Fat Atrophy
on Jan 20, 2004 Female patient from , 36 years of age, weighting 132.3 lb, was diagnosed with dermatitis allergic and was treated with Kenalog-10 (View Usage). After Kenalog-10 was administered, patient had the following side effects: fat atrophy. Kenalog-10 dosage: .

4562386-7 | Pruritus, Urticaria
on Sep 23, 2003 Male patient from , 30 years of age, weighting 288.8 lb, was diagnosed with alopecia areata and was treated with Kenalog-10 (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, urticaria. Kenalog-10 dosage: .

4562385-5 | Eye Swelling, Lacrimation Increased, Sneezing
Patient was taking Kenalog-10 (View Usage). Patient had the following side effects: eye swelling, lacrimation increased, sneezing on Sep 23, 2003 from Additional patient health information: Male patient , 81 years of age, weighting 213.8 lb, was diagnosed with psoriasis and. Kenalog-10 dosage: . During the same period patient was treated with SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), POTASSIUM (View Potassium Review and Potassium Label ).